Table 1 Clinical data of patients with HNSCC
# (%) | Median age at diagnosis (range) | Median observation time (range) | |||
|---|---|---|---|---|---|
Women | 14 (21.9%) | 56.5 (48–76) years | 13 (2–53) months | ||
Men | 50 (78.1%) | 57 (34–78) years | 22 (2–61) months | ||
Deceased | 42 (65.6%) | ||||
Status unknown | 3 (4.7%) | ||||
Disease reoccurrence | 3 (4.7%) | ||||
Tumor locations | # (%) | ||||
Oral cavity | 34 (53.1%) | ||||
Oropharynx | 25 (39.1%) | ||||
Hypopharynx | 5 (7.8%) | ||||
TNM classification | |||||
Tumor | # (%) | Lymph node status | # (%) | Distant metastases | # (%) |
T1 | 8 (12.5%) | N0 | 22 (34.4%) | M0 | 61 (95.3%) |
T2 | 16 (25.0%) | N1 or higher | 42 (65.6%) | M1 | 3 (4.7%) |
T3 | 7 (10.9%) | ||||
T4 | 33 (51.6%) | ||||
Disease stage | # (%) | Histologic grading | # (%) | ||
I | 6 (9.4%) | grade 1 | 12 (18.7%) | ||
II | 8 (12.5%) | grade 2 | 36 (56.3%) | ||
III | 3 (4.7%) | grade 3 | 16 (25.0%) | ||
IVA | 37 (57.8%) | ||||
IVB | 7 (10.9%) | ||||
IVC | 3 (4.7%) | ||||
Cancer treatment applied | # (%) | ||||
Radical surgery | 13 (20.3%) | ||||
Radical surgery & Chemotherapy & Radiotherapy | 13 (20.3%) | ||||
Radical surgery & Radiotherapy | 18 (28.1%) | ||||
Chemotherapy & Radiotherapy | 10 (15.6%) | ||||
Radiotherapy | 8 (12.5%) | ||||
No therapy | 2 (3.1%) | ||||